PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
From:
Published online 2011 February 18. doi: 10.1080/00273171.2011.540480

TABLE 3

Baseline Characteristics of Treated and Untreated Participants in the Final Propensity Score Matched Sample

VariableNo Smoking Cessation Counseling (N = 646)Smoking Cessation Counseling (N = 646)Standardized Difference of the MeanVariance Ratio
Demographic Characteristics
Age59.1 ± 12.458.7 ± 12.40.0260.998
Female178 (27.6%)175 (27.1%)0.0100.989

Presenting Signs and Symptoms
Acute pulmonary edema31 (4.8%)25 (3.9%)0.0460.814

Vital Signs on Admission
Systolic blood pressure147.7 ± 30.5147.8 ± 31.30.0021.055
Diastolic blood pressure85.5 ± 17.785.7 ± 18.50.0151.092
Heart rate82.1 ± 22.482.4 ± 22.30.0130.993
Respiratory rate20.8 ± 5.520.9 ± 5.70.0121.046

Classic Cardiac Risk Factors
Diabetes130 (20.1%)140 (21.7%)0.0381.056
Hyperlipidemia216 (33.4%)214 (33.1%)0.0070.995
Hypertension247 (38.2%)247 (38.2%)0.0001.000
Family history of coronary artery disease218 (33.7%)235 (36.4%)0.0551.035

Comorbid Conditions and Vascular History
Cerebrovascular accident/Transient ischemic attack 39 (6.0%)46 (7.1%)0.0441.166
Angina165 (25.5%)166 (25.7%)0.0041.004
Cancer15 (2.3%)13 (2.0%)0.0210.869
Dementia5 (0.8%)8 (1.2%)0.0471.593
Previous myocardial infarction131 (20.3%)131 (20.3%)0.0001.000
Asthma33 (5.1%)35 (5.4%)0.0141.057
Depression63 (9.8%)63 (9.8%)0.0001.000
Peptic ulcer disease30 (4.6%)30 (4.6%)0.0001.000
Peripheral vascular disease57 (8.8%)57 (8.8%)0.0001.000
Previous coronary revascularization44 (6.8%)43 (6.7%)0.0060.979
Chronic congestive heart failure13 (2.0%)14 (2.2%)0.0111.075

Laboratory Tests
Glucose9.0 ± 5.39.1 ± 5.50.0111.075
White blood count10.9 ±i 3.910.7 ± 3.60.0380.863
Hemoglobin143.2 ± 16.7143.9 ± 17.60.0411.117
Sodium139.1 ± 3.5139.0 ± 3.30.0250.920
Potassium4.0 ± 0.54.1 ± 0.50.0041.151
Creatinine93.8 ± 39.692.1 ± 40.20.0451.033

Prescriptions for Cardiovascular Medications at Hospital Discharge
Statin189 (29.3%)185 (28.6%)0.0140.987
Beta-blocker424 (65.6%)427 (66.1%)0.0100.993
Angiotensin Converting Enzyme (ACE) inhibitor/Angiotensin receptor blockers302 (46.7%)309 (47.8%)0.0221.002
Plavix24 (3.7%)28 (4.3%)0.0311.159
Acetylsalicyclic Acid (ASA)476 (73.7%)488 (75.5%)0.0430.953

Note. Continuous variables are presented as means ± standard deviation; dichotomous variables are presented as N (%).